Neurology | Page 28 of 81 | Links Medicus Content Curation & Alerts in Medicine

Predicting good neuro outcome in comatose cardiac arrest survivors? Look at
🧠 GCS motor 4/5
🧠 normal NSE
🧠 SSEP N20 wave amplitude > 4 μV or continuous EEG background without discharges
🧠 no diffusion restriction in cortex or deep grey matter on MRI
SR https://t.co/ixkMvErdux pic.twitter.com/GjeuTLgDlb

— Intensive Care Medicine (@yourICM) March 4, 2022

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review.

6 Mar, 2022 | 23:38h | UTC

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review – Critical Care

Cohort Study: Association between screen time exposure in children at 1 year of age and autism spectrum disorder at 3 years of age.

4 Mar, 2022 | 09:54h | UTC

Association Between Screen Time Exposure in Children at 1 Year of Age and Autism Spectrum Disorder at 3 Years of Age: The Japan Environment and Children’s Study – JAMA Pediatrics

Commentary: Screen Time Linked to Autism Spectrum Disorder in Boys – HealthDay

M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.

Media and Young Minds – American Academy of Pediatrics

Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents – “children below 2 years age should not be exposed to any type of screen, whereas exposure should be limited to a maximum of one hour of supervised screen time per day for children 24-59 months age, and less than two hours per day for children 5-10 years age”.

Association between incident cancer and Guillain-barré syndrome development: a nationwide case-control study.

4 Mar, 2022 | 08:33h | UTC

Association Between Incident Cancer and Guillain-Barré Syndrome Development: A Nationwide Case-Control Study – Neurology (link to abstract – $ for full-text)

News Release: Certain Types of Cancer May Increase the Risk of Developing Guillain-Barré – American Academy of Neurology

RCT: Aspirin and unfractionated heparin increase the risk of symptomatic intracranial hemorrhage in patients undergoing endovascular treatment for ischemic stroke.

3 Mar, 2022 | 08:53h | UTC

Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial – The Lancet (link to abstract – $ for full-text)

Postcraniotomy Headache: Etiologies and treatments.

3 Mar, 2022 | 07:55h | UTC

Postcraniotomy Headache: Etiologies and Treatments – Current Pain and Headache Reports

RCT: Prophylactic melatonin does not reduce the incidence of delirium in intensive care patients.

1 Mar, 2022 | 08:45h | UTC

Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial – Intensive Care Medicine (link to abstract – $ for full-text)

Commentaries on Twitter

Enteral prophylactic melatonin initiated early (within 48h of admission) & continued throughout #ICU (MAX 14 consecutive days) do not ⬇️#delirium prevalence vs placebo, Pro-MEDIC multicentre RCT
➡️12🇦🇺ICUs
➡️841 pts
➡️delirium-free assessments 79.2% vs 80%https://t.co/Gt5o1VuRo7 pic.twitter.com/gPRWxxmhHS

— Intensive Care Medicine (@yourICM) February 28, 2022

In 841 ICU patients with expected stay >72h, 4 mg melatonin within 48h after admission for 14 days vs placebo made no sign. differences in delirium-free assessments, LoS, 90d mortality, nor quality & quantity of sleep
Good bye Melatonin, we had a good timehttps://t.co/d0dayil99W

— Peter Nydahl (@NydahlPeter) February 28, 2022

RCT: A mindfulness-oriented intervention may reduce opioid misuse and chronic pain in primary care.

1 Mar, 2022 | 08:32h | UTC

Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary: Mindfulness-Based Intervention Found to Reduce Chronic Pain and Opioid Misuse – Psychiatric News Alert

Commentary on Twitter

A randomized clinical trial showed that #Mindfulness-Oriented Recovery Enhancement delivered in the primary care setting reduces opioid misuse by as much as 46%, while simultaneously reducing chronic pain and emotional distress. https://t.co/eNj42RBCRA @DrEricGarland pic.twitter.com/tBatMT9lkQ

— JAMA Internal Medicine (@JAMAInternalMed) February 28, 2022

Review: New generation psychological treatments in chronic pain.

1 Mar, 2022 | 08:41h | UTC

New generation psychological treatments in chronic pain – The BMJ (free for a limited period)

Meta-analysis suggests there is low risk of delayed intracranial hemorrhage (after a negative initial head CT) following low energy blunt head trauma while on direct oral anticoagulants.

27 Feb, 2022 | 22:30h | UTC

Delayed Intracranial Hemorrhage Following Blunt Head Trauma While on Direct Oral Anticoagulants: A Systematic Review and Meta-analysis – Journal of the American College of Surgeons

RCT: In comatose survivors of cardiac arrest, a strategy of suppressing rhythmic and periodic EEG activity with the use of antiseizure medication did not improve neurologic outcomes.

24 Feb, 2022 | 10:45h | UTC

Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary on Twitter

In trial of comatose patients after cardiac arrest, intensive antiseizure treatment adapted from protocols for status epilepticus did not result in fewer poor outcomes at 3 mos than standard treatment. https://t.co/dpH5cgwhvW pic.twitter.com/zVBHBYMRK9

— NEJM (@NEJM) February 23, 2022

RCT: Sublingual dexmedetomidine reduces mild to moderate acute agitation in patients with bipolar disorder.

23 Feb, 2022 | 10:18h | UTC

Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Sublingual Dexmedetomidine as a Potential New Treatment for Agitation – JAMA (free for a limited period)

Commentary on Twitter

Randomized clinical trial found sublingual #dexmedetomidine at a dose of 180 μg or 120 μg reduced mild to moderate agitation in patients with #bipolar disorder. https://t.co/1VK2e15F7s pic.twitter.com/0oHw6eVMIP

— JAMA (@JAMA_current) February 22, 2022

M-A: Combining antidepressants vs. antidepressant monotherapy for treatment of patients with acute depression.

22 Feb, 2022 | 08:40h | UTC

Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression: A Systematic Review and Meta-analysis – JAMA Psychiatry (free for a limited period)

M-A of randomized trials | Association between intensity of LDL cholesterol reduction with statin-based therapies and secondary stroke prevention.

22 Feb, 2022 | 08:37h | UTC

Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials – JAMA Neurology

Editorial: Low-Density Lipoprotein Cholesterol Level After a Stroke—Reducing It by Any Means (free for a limited period)

Early and late-onset syncope: insight into mechanisms.

22 Feb, 2022 | 08:29h | UTC

Early and late-onset syncope: insight into mechanisms – European Heart Journal

Commentary on Twitter

Early and late-onset syncope: insight into mechanisms https://t.co/OlAT50jIt8 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/F2gzBH9X2i

— European Society of Cardiology Journals (@ESC_Journals) February 17, 2022

Review: Acute ischemic stroke and its challenges for the intensivist.

22 Feb, 2022 | 08:27h | UTC

Acute ischaemic stroke and its challenges for the intensivist – European Heart Journal. Acute Cardiovascular Care

Review | Acute traumatic brain injury in frail patients: the next pandemic.

21 Feb, 2022 | 08:31h | UTC

Acute traumatic brain injury in frail patients: the next pandemic – Current Opinion in Critical Care

Stay Updated in Your Specialty